BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Iopofosine I-131 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Iopofosine I-131\, from ClinicalTrials.go
 v estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05610891-3317@assetmemo.bio
DTSTAMP:20261121T005951Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:Iopofosine I-131: Phase 1 readout est. (NCT05610891)
DESCRIPTION:Iopofosine I-131\, phase 1.\nStudy: Novel Targeted Radiotherapy
  in Pediatric Patients With Inoperable Relapsed or Refractory HGG\nEstimat
 ed primary completion: 30 June 2027. This is a ClinicalTrials.gov estimate
 \, not a confirmed readout date\, and it can move.\nDrug page: https://ass
 etmemo.bio/drug/iopofosine-i-131#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT05610891
URL:https://assetmemo.bio/drug/iopofosine-i-131#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT03478462-3317@assetmemo.bio
DTSTAMP:20261121T005951Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:Iopofosine I-131: Phase 1 readout est. (NCT03478462)
DESCRIPTION:Iopofosine I-131\, phase 1.\nStudy: Dose Escalation Study of CL
 R 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neurobla
 stoma and Sarcomas\nEstimated primary completion: 30 June 2027. This is a 
 ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can mo
 ve.\nDrug page: https://assetmemo.bio/drug/iopofosine-i-131#upcoming-event
 s\nRegistry record: https://clinicaltrials.gov/study/NCT03478462
URL:https://assetmemo.bio/drug/iopofosine-i-131#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07766421-3317@assetmemo.bio
DTSTAMP:20261121T005951Z
DTSTART;VALUE=DATE:20320131
DTEND;VALUE=DATE:20320201
SUMMARY:Iopofosine I-131: Phase 3 readout est. (NCT07766421)
DESCRIPTION:Iopofosine I-131\, phase 3\, Waldenstrom's Macroglobulinemia.\n
 Study: Evaluation of Iopofosine I 131 vs. R-CD in WM Patients\nEstimated p
 rimary completion: January 2032. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/iopofosine-i-131#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT07766421
URL:https://assetmemo.bio/drug/iopofosine-i-131#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
